Download Files:
Rezivertinib analogue 1
SKU
HY-148053-10 mg
Category Reference compound
Tags Cancer, Drug Metabolite, Metabolic Enzyme/Protease
$100 – $950
Products Details
Product Description
– Rezivertinib analogue 1 is a process impurity of osimertinib mesylate. Rezivertinib analogue 1 can be used in the study of non-small cell lung cancer[1].
Web ID
– HY-148053
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C27H33N7O2
References
– [1] Huijuan Jia, et al. The methanesulfonic acid uncommon preparation method for Buddhist nun’s process contaminants difficult to understand. Patent CN108017620A.
CAS Number
– 2227103-37-7
Molecular Weight
– 487.60
Compound Purity
– 99.68
SMILES
– O=C(C)NC1=CC(NC2=NC(C3=CN(C)C4=C3C=CC=C4)=CC=N2)=C(C=C1N(CCN(C)C)C)OC
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– DMSO : 50 mg/mL (ultrasonic;warming;heat to 60°C)
Target
– Drug Metabolite
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.